Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any azoospermia in which the cause of the disease is a mutation in the ZMYND15 gene.
Features include always present findings: Round spermatid arrest, Male infertility, Elevated circulating follicle stimulating hormone level, and Azoospermia. 7 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Hormones | 1 | Male infertility |
ZMYND15 function has not been fully characterized.
Spermatogenic failure 14 is associated with mutations in the ZMYND15 gene on chromosome 17.
Genetic testing for ZMYND15 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for spermatogenic failure 14 has been reported in the published literature.
Phenotype severity distribution: 4 always present features.
No clinical trials have been registered for spermatogenic failure 14.
13 publications have been identified in PubMed for spermatogenic failure 14. Research spans Basic Science / Preclinical (38%), Diagnostic / Biomarker (15%), and Review / Meta-Analysis (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 5 | 38% |
Data assembled from 5 of 12 sources · Last updated Sep 17, 2026, 7:43 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
1 |
Elevated circulating follicle stimulating hormone level |
2 |
15% |
Research summaries | 2 | 15% |
Disease patterns and progression | 2 | 15% |
Patient case studies | 1 | 8% |
New treatment approaches | 1 | 8% |
Zikopoulos A (2026). [PMID: 42072331](https://pubmed.ncbi.nlm.nih.gov/42072331/). *Biomedicines*. [Review / Meta-Analysis]
Dubey P (2026). [PMID: 41931224](https://pubmed.ncbi.nlm.nih.gov/41931224/). *Biochem Genet*. [Diagnostic / Biomarker]
Caroppo E (2026). [PMID: 40220323](https://pubmed.ncbi.nlm.nih.gov/40220323/). *Andrology*. [Case Report / Case Series]
Atkins GR (2026). [PMID: 41756962](https://pubmed.ncbi.nlm.nih.gov/41756962/). *bioRxiv*. [Basic Science / Preclinical]
Yao W (2025). [PMID: 40376536](https://pubmed.ncbi.nlm.nih.gov/40376536/). *Transl Androl Urol*. [Diagnostic / Biomarker]
Valkna A (2025). [PMID: 40060932](https://pubmed.ncbi.nlm.nih.gov/40060932/). *Hum Reprod Open*. [Epidemiology / Natural History]
Wei C (2025). [PMID: 40240737](https://pubmed.ncbi.nlm.nih.gov/40240737/). *J Assist Reprod Genet*. [Gene Therapy / Novel Therapeutics]
Wang X (2025). [PMID: 41339899](https://pubmed.ncbi.nlm.nih.gov/41339899/). *Reprod Biol Endocrinol*. [Review / Meta-Analysis]
Li X (2024). [PMID: 38798119](https://pubmed.ncbi.nlm.nih.gov/38798119/). *Environ Toxicol*. [Basic Science / Preclinical]
Faizah Z (2024). [PMID: 39553750](https://pubmed.ncbi.nlm.nih.gov/39553750/). *Open Vet J*. [Basic Science / Preclinical]